Dr. Scot W. Ebbinghaus MD Hematologist

Dr. Scot Ebbinghaus is a hematologist in Philadelphia, Pennsylvania. He is affiliated with multiple hospitals in the area, including Fox Chase Cancer Center-American Oncologic Hospital and Temple University Hospital. He received his medical degree from University of Missouri - Kansas City School of Medicine and has been in practice for 25 years. He is one of 6 doctors at Fox Chase Cancer Center-American Oncologic Hospital and one of 15 at Temple University Hospital who specialize in Hematology.

Are you Dr. Scot Ebbinghaus? Claim your profile to make edits or add details. Claim/Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Hematologist: General Hematology

Hospital Affiliation

Fox Chase Cancer Center-American Oncologic Hospital
Ranked #30 in Cancer

Temple University Hospital
High performing in Cancer

Education & Medical Training

University of Alabama Medical Center
Residency, Internal Medicine, 1989 - 1993

University of Alabama Medical Center
Fellowship, Hematology/Oncology, 1993 - 1996

University of Missouri - Kansas City School of Medicine
Class of 1989

Certifications & Licensure

American Board of Internal Medicine
Certified in Hematology

American Board of Internal Medicine
Certified in Internal Medicine

American Board of Internal Medicine
Certified in Medical Oncology

PA State Medical License
Active through 2014

Publications & Presentations

Tolerability, safety and pharmacokinetics of ridaforolimus in combination with bicalutamide in patients with asymptomatic, metastatic castration-resistant prostate cancer (CRPC).
Meulenbeld, H. J.,de Bono, J. S.,Tagawa, S. T.,Whang, Y. E.,Li, X.,Heath, K. H.,Zandvliet, A. S.,Ebbinghaus, S. W.,Hudes, G. R.,de Wit, R.

Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.
Hamid, O.,Robert, C.,Daud, A.,Hodi, F. S.,Hwu, W. J.,Kefford, R.,Wolchok, J. D.,Hersey, P.,Joseph, R. W.,Weber, J. S.,Dronca, R.,Gangadhar, T. C.,Patnaik, A.,Zarour, H.,Joshua, A. M.,Gergich, K.,Elassaiss-Schaap, J.,Algazi, A.,Mateus, C.,Boasberg, P.,Tumeh, P. C.,Chmielowski, B.,Ebbinghaus, S. W.,Li, X. N.,Kang, S. P.,Ribas, A.

Voreloxin, a first-in-class anticancer quinolone derivative, in relapsed/refractory solid tumors: a report on two dosing schedules.
Advani, R.H., Hurwitz, H.I., Gordon, M.S., Ebbinghaus, S.W., Mendelson, D.S., Wakelee, H.A., Hoch, U., Silverman, J.A., Havrilla, N.A., Berman, C.J., Fox, J.A., Allen, R.S., Adelman, D.C.

See all 20 publications

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • AmeriHealth Direct POS
  • Amerihealth HMO
  • AmeriHealth PPO
  • BCBS Blue Card PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • Great West PPO
  • IBC Keystone HMO / POS
  • IBC Personal Choice PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • QualCare HMO
  • QualCare PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.